Houston Garcia
About Houston Garcia
Houston Garcia is a Process Engineer I at Kite Pharma, where he has worked since 2022. He holds a Bachelor's degree in Health Services from Azusa Pacific University and is currently pursuing an MBA at Golden Gate University.
Work at Kite Pharma
Houston Garcia currently holds the position of Process Engineer I at Kite Pharma, where he has been employed since 2022 in El Segundo, California. His career at Kite Pharma began in 2019 when he joined as an Allogeneic Research Intern. He then progressed to roles including Cell Therapy Specialist I and Cell Therapy Specialist II+, demonstrating a trajectory of growth within the organization. His experience spans various aspects of cell therapy and process engineering, contributing to the company's advancements in biopharmaceuticals.
Education and Expertise
Houston Garcia earned a Bachelor's degree in Health Services/Allied Health/Health Sciences from Azusa Pacific University, completing his studies from 2014 to 2018. He furthered his education by obtaining a Master's degree in Biotechnology from the same institution, which he completed in 2020. Currently, he is pursuing a Master of Business Administration (MBA) at Golden Gate University, expected to conclude in 2024. His educational background equips him with a blend of scientific and business knowledge relevant to his roles in the biotechnology sector.
Background
Houston Garcia's professional journey began at Azusa Pacific University, where he worked as a Library Assistant from 2018 to 2019. His transition into the biotechnology field started with an internship at Kite Pharma, which laid the foundation for his subsequent roles in cell therapy. His diverse experiences within Kite Pharma reflect a commitment to advancing his career in the biopharmaceutical industry, particularly in process engineering and cell therapy.
Career Progression
Houston Garcia's career at Kite Pharma illustrates a clear progression through various roles. Starting as an Allogeneic Research Intern in 2019, he quickly moved to Cell Therapy Specialist I, followed by Cell Therapy Specialist II+. In 2022, he transitioned to the role of Process Engineer I. His varied positions within the company highlight his adaptability and growth in the field of biotechnology.